Comparison of Frequency of Use of Optive and Systane

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is subjectively compare duration of action between Optive and Systane.

• Phase: Phase 4

Details

• Lead Sponsor: Innovative Medical

Criteria

Inclusion Criteria:

• Males or females > 18 years old

• Mild to moderate dry eye symptoms

• Score of at least 2 and no more than 4 on the SESOD at the initial screening visit

• Likely to complete all study visits and able to provide informed consent

Exclusion Criteria:

• Current use of topical cyclosporine

• Known contraindications to any study medication or ingredients

• Active ocular diseases or uncontrolled systemic disease (blepharitis patients that are actively being treated or disease that is uncontrollable)

• Ocular surgery within the past 3 months,

• Active ocular allergies